SUNITINIB IN ADVANCED CLEAR CELL RENAL CANCER: A SINGLE CENTRE EXPERIENCE

被引：0
|
作者：
Bruni, G. S. [1 ]
Facchini, G. [1 ]
Iaffaioli, V. R. [1 ]
Pisano, C. [1 ]
Pignata, S. [1 ]
机构：
[1] Natl Canc Inst Naples, Urogynecol Dept, Naples, Italy
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 14期
关键词：
D O I：
10.1016/j.ejcsup.2008.06.046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [21] Sunitinib for treatment of advanced renal cell cancer: Primary tumor response
    Van der Veldt, Astrid A. M.
    Meijerink, Martijn R.
    Van den Eertwegh, AlfonsJ. M.
    Bex, Axel
    Gast, Gijsbert Cle
    Haanen, John B. A. G.
    Boven, Epie
    CLINICAL CANCER RESEARCH, 2008, 14 (08) : 2431 - 2436
  • [22] Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
    Stewart, Grant D.
    Powles, Thomas
    Van Neste, Christophe
    Meynert, Alison
    O'Mahony, Fiach
    Laird, Alexander
    Deforce, Dieter
    Van Nieuwerburgh, Filip
    Trooskens, Geert
    Van Criekinge, Wim
    De Meyer, Tim
    Harrison, David J.
    ONCOTARGET, 2016, 7 (18) : 25241 - 25250
  • [23] The safety and efficacy of sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer
    Powles, T.
    Kayani, I.
    Blank, C. U.
    Chowdhury, S.
    Horenblas, S.
    Sarwar, N.
    Nathan, P. D.
    Boleti, E.
    Haanen, J. B.
    Bex, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Safety and activity of sorafenib in advanced renal cell cancer: A single institution experience
    Bajetta, E.
    Procopio, G.
    Verzoni, E.
    Mancin, M.
    Pusceddu, S.
    Bajetta, R.
    Galassi, M.
    Gevorgyan, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] The effect of sunitinib on biomarkers and tumor heterogeneity in metastatic clear cell renal cancer.
    Stewart, Grant
    Laird, Alexander
    O'Mahony, Fiach
    Eory, Lel
    Lubbock, Alexander
    Nanda, Jyoti
    O'Donnell, Marie
    Mackay, Alan
    Mullen, Peter
    McNeill, Alan
    Riddick, Antony
    Aitchison, Michael
    Berney, Daniel
    Bex, Axel
    Overton, Ian
    Harrison, David James
    Powles, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [26] The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer
    Powles, T.
    Kayani, I.
    Blank, C.
    Chowdhury, S.
    Horenblas, S.
    Peters, J.
    Shamash, J.
    Sarwar, N.
    Boletti, K.
    Sadev, A.
    O'Brien, T.
    Berney, D.
    Beltran, L.
    Haanen, J.
    Bex, A.
    ANNALS OF ONCOLOGY, 2011, 22 (05) : 1041 - 1047
  • [27] SUNITINIB-RELATED PSORIASIS REMISSION IN PATIENTS AFFECTED BY ADVANCED CLEAR CELL RENAL CELL CARCINOMA (RCC)
    Bramati, A.
    Girelli, S.
    Garassino, M. C.
    Piva, S.
    La Verde, N.
    Sburlati, P.
    Moretti, A.
    Bianchi, A.
    Celso, B.
    Farina, G.
    ANNALS OF ONCOLOGY, 2010, 21 : 398 - 398
  • [28] Real world outcomes of patients with non-clear cell renal cell carcinoma: A single Asian centre experience.
    Chan, Johan W. K.
    Peh, Daniel
    Tan, Wei Chong
    Tan, Hui Shan
    Ng, Quan Sing
    Rajasekaran, Tanujaa
    Teh, Yi Lin
    Saw, Stephanie
    Tan, Wan Ling
    Lai, Gillianne
    Jain, Amit
    Kanesvaran, Ravindran
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [29] Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib
    Zimmermann, Kaja
    Schmittel, Alexander
    Steiner, Ursula
    Asemissen, Anne Marie
    Knoedler, Maren
    Thiel, Eckhard
    Miller, Kurt
    Keilholz, Ulrich
    ONCOLOGY, 2009, 76 (05) : 350 - 354
  • [30] Pain relief of advanced cancer patients: the experience of a single centre
    Liu, DQ
    EUROPEAN JOURNAL OF PAIN-LONDON, 2001, 5 : 127 - 128
12345